✦ LIBER ✦

PMC16 EXPENSIVE DRUGS FOR RARE DISORDERS AND THE LOGIC OF COST-EFFECTIVENESS

✍ Scribed by M Schlander

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biomarkers: improving the cost-effective

✍ David Gurwitz 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

PMC12 THE COST-EFFECTIVENESS OF BIOLOGIC

✍ R Fleurence; E Spackman 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

Expensive drugs for rare disorders: to t

✍ Schlander, M.; Beck, M. 📂 Article 📅 2009 🏛 Informa plc 🌐 English ⚖ 130 KB

16 The Effectiveness and Cost Effectiven

✍ J. Hughes; A. Molassiotis; W. Russell; M. Breckons; M. Lloyd-Williams; J. Richar 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 50 KB

The cost and effectiveness of adherence-

✍ R. H. Chapman; C. P. Ferrufino; S.L. Kowal; P. Classi; C. S. Roberts 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB

The Lag between Effectiveness and Cost-E

✍ Boyka Stoykova, Michael Drummond, Marco Barbieri and Jos Kleijnen 📂 Article 📅 2003 🏛 Springer 🌐 French ⚖ 1001 KB